DYR1B_HUMAN - dbPTM
DYR1B_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID DYR1B_HUMAN
UniProt AC Q9Y463
Protein Name Dual specificity tyrosine-phosphorylation-regulated kinase 1B
Gene Name DYRK1B
Organism Homo sapiens (Human).
Sequence Length 629
Subcellular Localization Nucleus.
Protein Description Dual-specificity kinase which possesses both serine/threonine and tyrosine kinase activities. Enhances the transcriptional activity of TCF1/HNF1A and FOXO1. Inhibits epithelial cell migration. Mediates colon carcinoma cell survival in mitogen-poor environments. Inhibits the SHH and WNT1 pathways, thereby enhancing adipogenesis. In addition, promotes expression of the gluconeogenic enzyme glucose-6-phosphatase (G6PC)..
Protein Sequence MAVPPGHGPFSGFPGPQEHTQVLPDVRLLPRRLPLAFRDATSAPLRKLSVDLIKTYKHINEVYYAKKKRRAQQAPPQDSSNKKEKKVLNHGYDDDNHDYIVRSGERWLERYEIDSLIGKGSFGQVVKAYDHQTQELVAIKIIKNKKAFLNQAQIELRLLELMNQHDTEMKYYIVHLKRHFMFRNHLCLVFELLSYNLYDLLRNTHFRGVSLNLTRKLAQQLCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGTPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMNRIVEVLGIPPAAMLDQAPKARKYFERLPGGGWTLRRTKELRKDYQGPGTRRLQEVLGVQTGGPGGRRAGEPGHSPADYLRFQDLVLRMLEYEPAARISPLGALQHGFFRRTADEATNTGPAGSSASTSPAPLDTCPSSSTASSISSSGGSSGSSSDNRTYRYSNRYCGGPGPPITDCEMNSPQVPPSQPLRPWAGGDVPHKTHQAPASASSLPGTGAQLPPQPRYLGRPPSPTSPPPPELMDVSLVGGPADCSPPHPAPAPQHPAASALRTRMTGGRPPLPPPDDPATLGPHLGLRGVPQSTAASS
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
41PhosphorylationPLAFRDATSAPLRKL
CCCCCCCCCCCHHHC
29.7025072903
42PhosphorylationLAFRDATSAPLRKLS
CCCCCCCCCCHHHCH
29.6125072903
49PhosphorylationSAPLRKLSVDLIKTY
CCCHHHCHHHHHHHH
19.3420873877
57AcetylationVDLIKTYKHINEVYY
HHHHHHHHHHHHHHH
43.1522643183
63PhosphorylationYKHINEVYYAKKKRR
HHHHHHHHHHHHHHH
7.4828152594
64PhosphorylationKHINEVYYAKKKRRA
HHHHHHHHHHHHHHH
19.6828152594
662-HydroxyisobutyrylationINEVYYAKKKRRAQQ
HHHHHHHHHHHHHHC
42.58-
79PhosphorylationQQAPPQDSSNKKEKK
HCCCCCCCCCHHHHH
30.4824260401
92PhosphorylationKKVLNHGYDDDNHDY
HHHHHCCCCCCCCCE
14.51-
111PhosphorylationGERWLERYEIDSLIG
CCHHHHHEECHHEEE
14.09-
115PhosphorylationLERYEIDSLIGKGSF
HHHEECHHEEECCCH
27.7830576142
119UbiquitinationEIDSLIGKGSFGQVV
ECHHEEECCCHHHHE
44.37-
121PhosphorylationDSLIGKGSFGQVVKA
HHEEECCCHHHHEEE
29.6830576142
127UbiquitinationGSFGQVVKAYDHQTQ
CCHHHHEEECCCCCC
42.23-
129PhosphorylationFGQVVKAYDHQTQEL
HHHHEEECCCCCCEE
14.29-
171PhosphorylationQHDTEMKYYIVHLKR
HCCHHHHHHHHHHHH
9.34-
214PhosphorylationRGVSLNLTRKLAQQL
CCCCHHHHHHHHHHH
25.3722985185
256UbiquitinationNPKRSAIKIVDFGSS
CCCCCCEEEEECCCC
36.07-
262PhosphorylationIKIVDFGSSCQLGQR
EEEEECCCCCHHHHH
28.1223665168
263PhosphorylationKIVDFGSSCQLGQRI
EEEECCCCCHHHHHH
13.2829514088
271PhosphorylationCQLGQRIYQYIQSRF
CHHHHHHHHHHHHHH
9.4621945579
273PhosphorylationLGQRIYQYIQSRFYR
HHHHHHHHHHHHHCC
5.5119664994
276PhosphorylationRIYQYIQSRFYRSPE
HHHHHHHHHHCCCHH
18.1321945579
356PhosphorylationRLPGGGWTLRRTKEL
CCCCCCCHHHCCHHH
17.4229449344
360PhosphorylationGGWTLRRTKELRKDY
CCCHHHCCHHHHHHC
23.5729449344
401PhosphorylationPGHSPADYLRFQDLV
CCCCHHHHHHHHHHH
11.24-
421PhosphorylationYEPAARISPLGALQH
CCCCCCCCCCHHHHH
14.4424719451
446PhosphorylationTNTGPAGSSASTSPA
CCCCCCCCCCCCCCC
25.4927251275
447PhosphorylationNTGPAGSSASTSPAP
CCCCCCCCCCCCCCC
25.8927251275
449PhosphorylationGPAGSSASTSPAPLD
CCCCCCCCCCCCCCC
31.2227251275
450PhosphorylationPAGSSASTSPAPLDT
CCCCCCCCCCCCCCC
38.1527251275
451PhosphorylationAGSSASTSPAPLDTC
CCCCCCCCCCCCCCC
19.3027251275
485PhosphorylationSDNRTYRYSNRYCGG
CCCCCEEECCCCCCC
10.41-
486PhosphorylationDNRTYRYSNRYCGGP
CCCCEEECCCCCCCC
13.06-
554PhosphorylationRYLGRPPSPTSPPPP
CCCCCCCCCCCCCCC
43.4228348404
556PhosphorylationLGRPPSPTSPPPPEL
CCCCCCCCCCCCCHH
59.1928348404
557PhosphorylationGRPPSPTSPPPPELM
CCCCCCCCCCCCHHC
38.5028348404
576PhosphorylationVGGPADCSPPHPAPA
CCCCCCCCCCCCCCC
41.8528348404
594PhosphorylationPAASALRTRMTGGRP
HHHHHHHHHHCCCCC
26.1622210691
624PhosphorylationGLRGVPQSTAASS--
CCCCCCCHHCCCC--
17.5926853621
625PhosphorylationLRGVPQSTAASS---
CCCCCCHHCCCC---
22.4626853621

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
271YPhosphorylationKinaseDYR1BQ9Y463
PhosphoELM
273YPhosphorylationKinaseDYR1BQ9Y463
PhosphoELM
421SPhosphorylationKinaseDYRK1BQ9Y463
PSP
421SPhosphorylationKinaseMAPK1P28482
GPS

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of DYR1B_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of DYR1B_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
RANB9_HUMANRANBP9physical
14500717
HDAC5_HUMANHDAC5physical
15546868
DCAF7_HUMANDCAF7physical
20940704
DCAF7_HUMANDCAF7physical
21777625
RBL1_HUMANRBL1physical
23602568
RB_HUMANRB1physical
23602568
LZTS2_HUMANLZTS2physical
23602568
TROAP_HUMANTROAPphysical
23602568
CDN2A_HUMANCDKN2Aphysical
23602568
ARF_HUMANCDKN2Aphysical
23602568
AKA11_HUMANAKAP11physical
23602568
KAP0_HUMANPRKAR1Aphysical
23602568
RBL2_HUMANRBL2physical
23602568
CBP_HUMANCREBBPphysical
23602568
EP300_HUMANEP300physical
23602568
SKI_HUMANSKIphysical
23602568
F117B_HUMANFAM117Bphysical
23602568
DCAF7_HUMANDCAF7physical
23602568
GLCI1_HUMANGLCCI1physical
23602568
FA53C_HUMANFAM53Cphysical
23602568
F117A_HUMANFAM117Aphysical
23602568
RN169_HUMANRNF169physical
23602568
DYL1_HUMANDYNLL1physical
23602568
ABCD3_HUMANABCD3physical
23602568
SI1L1_HUMANSIPA1L1physical
23602568
WDR6_HUMANWDR6physical
23602568
ATD3B_HUMANATAD3Bphysical
23602568
SI1L3_HUMANSIPA1L3physical
23602568
SI1L2_HUMANSIPA1L2physical
23602568
ICE1_HUMANICE1physical
23602568
K0232_HUMANKIAA0232physical
23602568
ZN516_HUMANZNF516physical
23602568
ENAH_HUMANENAHphysical
23602568
LZTS3_HUMANLZTS3physical
23602568
TEBP_HUMANPTGES3physical
23602568
DDB1_HUMANDDB1physical
23602568
MS3L1_HUMANMSL3physical
23602568
ICE2_HUMANICE2physical
23602568
KAT8_HUMANKAT8physical
23602568
FOXK1_HUMANFOXK1physical
23602568
BMAL1_HUMANARNTLphysical
23602568
CCNA2_HUMANCCNA2physical
23602568
EP400_HUMANEP400physical
23602568
CTBP2_HUMANCTBP2physical
23602568
TCAL1_HUMANTCEAL1physical
23602568
KAPCA_HUMANPRKACAphysical
23602568
PPR3F_HUMANPPP1R3Fphysical
23602568
TECR_HUMANTECRphysical
23602568
IMB1_HUMANKPNB1physical
23602568
CHIP_HUMANSTUB1physical
23602568
UBP11_HUMANUSP11physical
23602568
ID2_HUMANID2physical
26735018
DYR1B_HUMANDYRK1Bphysical
26735018
DCAF7_HUMANDCAF7physical
27307198

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
615812Abdominal obesity-metabolic syndrome 3 (AOMS3)
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of DYR1B_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-57, AND MASS SPECTROMETRY.
Phosphorylation
ReferencePubMed
"Large-scale proteomics analysis of the human kinome.";
Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.;
Mol. Cell. Proteomics 8:1751-1764(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-273, AND MASSSPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-273, AND MASSSPECTROMETRY.
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis.";
Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III;
J. Proteome Res. 7:1346-1351(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-271 AND TYR-273, ANDMASS SPECTROMETRY.
"Phosphoproteome of resting human platelets.";
Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,Schuetz C., Walter U., Gambaryan S., Sickmann A.;
J. Proteome Res. 7:526-534(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-273, AND MASSSPECTROMETRY.
"Multiple reaction monitoring for robust quantitative proteomicanalysis of cellular signaling networks.";
Wolf-Yadlin A., Hautaniemi S., Lauffenburger D.A., White F.M.;
Proc. Natl. Acad. Sci. U.S.A. 104:5860-5865(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-273, AND MASSSPECTROMETRY.
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer.";
Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.;
Cell 131:1190-1203(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-273, AND MASSSPECTROMETRY.

TOP